Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation?
about
A model of gene-gene and gene-environment interactions and its implications for targeting environmental interventions by genotypeGenetics of coronary artery disease and myocardial infarctionMolecular basis for population variation: from SNPs to SAPsPatients' understanding of genetic susceptibility testing in mainstream medicine: qualitative study on thrombophiliaCardiovascular genomics: a biomarker identification pipelineGenetic tests: clinical validity and clinical utilityThe relationships between FAM5C SNP (rs10920501) variability and metabolic syndrome and inflammation in women with coronary heart diseaseAssessing the impact of a combined analysis of four common low-risk genetic variants on autism risk.Resampling procedures to identify important SNPs using a consensus approach.Genome paths: a way to personalized and predictive medicineInvestigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies.Managing scientific uncertainty in health legislation.Genetic testing for atherosclerosis risk: inevitability or pipe dream?Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism.Introducing genetic testing for cardiovascular disease in primary care: a qualitative studyGenetics and coronary heart disease.ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence aRole of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.[Assessment of cardiovascular risk--PROCAM and new algorithms]Determinants of risk factors of atherosclerosis in the postinfarction period: the Tallinn MI study.The use of Meta-Analysis Risk Estimates for Candidate Genes in Combination to Predict Coronary Heart Disease Risk
P2860
Q24288935-5BC8BE73-9CC6-4563-A0C6-9596F39B6226Q26769994-0C8E8A6E-A537-4953-8E8C-04AD43073B5AQ27002638-6CC776A2-2554-4904-B83F-8D802B1EEE2CQ28213173-A04270C8-546A-4876-B7FF-A93BF3635269Q28596902-E9D25299-D0B9-4E11-826C-CA38A5A3EDA2Q33856320-0A8CBB6C-FED6-4888-A341-2D3F77B54C74Q33942212-702483EA-4D06-4BFC-9458-B40ADA92F6DAQ34009782-4E0D75B2-2823-4D49-BF1F-882D56ABB9A1Q34176390-50663151-2DE5-44E4-87A3-AA1DA08AC879Q35944283-A359B7D0-B0EF-449B-A9C9-A22665896BDFQ36454338-F459BCF9-DD10-4ABA-85FB-67AC34045AE1Q36710362-47678491-4585-47B7-AD8B-334C89735597Q37101779-04188191-F44F-43E0-875A-B25C840112F3Q37138039-2C24072E-00B0-4F10-87CD-6680FD22114BQ37725784-DEE75F3E-60B6-4992-9C1E-E8B8B7EC0F92Q40457893-17DB65DF-F157-4C26-B3E0-6655E314D93AQ41877686-3A6E0246-71F7-4416-A30D-75784A54C23AQ46495908-9C1DF9EC-C911-4C86-82C0-A309235211CDQ46665154-621DC927-6F13-4727-AD67-33F270B26173Q54430137-39489A6C-F0FE-406F-BDCE-F7039837ABF7Q57900672-7D8DAE73-B0C0-4608-840E-CA71F7780506
P2860
Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Genetic testing for cardiovasc ...... ol or possible misinformation?
@ast
Genetic testing for cardiovasc ...... ol or possible misinformation?
@en
type
label
Genetic testing for cardiovasc ...... ol or possible misinformation?
@ast
Genetic testing for cardiovasc ...... ol or possible misinformation?
@en
prefLabel
Genetic testing for cardiovasc ...... ol or possible misinformation?
@ast
Genetic testing for cardiovasc ...... ol or possible misinformation?
@en
P1476
Genetic testing for cardiovasc ...... ol or possible misinformation?
@en
P2093
Paul M Ridker
Steve E Humphries
P304
P356
10.1161/01.ATV.0000116216.56511.39
P407
P577
2004-01-08T00:00:00Z